From gene-editing breakthroughs to blockbuster cystic fibrosis drugs, these two industry leaders present sharply contrasting ...

The use of genome editing in early embryos has pulled back the curtain on the role of one of the key genes that orchestrates ...

The opportunity is enormous, but uncertainty remains.

Base editing, the process used to make the changes, only nicks one strand of DNA, avoiding the major DNA errors that made ...

The inventor of the groundbreaking Crispr gene-editing technology is skeptical about artificial intelligence replacing human ...

One company dominates with an approved therapy, while the other bets on in vivo innovation. See how their financials and risk profiles stack up for 2026.

Its potential uses are considerable, although CRISPR Therapeutics got the ball rolling with a relatively modest one. Its gene-editing therapy Casgevy, approved in 2023, is aimed at the inherited blood ...

A 23-year-old man from Louisiana has become one of the first people in the United States to be functionally cured of sickle ...

A team of researchers led by Professor Akitsu Hotta (Department of Clinical Application) developed a comprehensive framework ...

In a rapidly changing climate landscape, the plants we rely on for food, textiles and more face a multitude of challenges, ...

The gene-editing niche of the biotech industry is gaining momentum, as various companies focused on these techniques -- which ...